Serum lipid studies in women using combination type of oral contraceptives.
D000367:Age Factors; D001695:Biology; D001723:Birth Rate; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D003710:Demography; D004997:Ethinyl Estradiol; D005193:Family Planning Services; D005298:Fertility; D008055:Lipids; D008234:Lynestrenol; D008656:Mestranol; D009644:Norgestrel; D010298:Parity; D010827:Physiology; D011153:Population; D011154:Population Characteristics; D011157:Population Dynamics; D011446:Prospective Studies; D012106:Research
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D008055:Lipids; D009644:Norgestrel; D004997:Ethinyl Estradiol; D008656:Mestranol; D008234:Lynestrenol
Age Factors; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Contraceptive Methods--side effects; Demographic Factors; Ethinyl Estradiol; Family Planning; Fertility; Fertility Measurements; Lipid Metabolic Effects; Lipids; Lynestrenol; Mestranol; Norgestrel; Oral Contraceptives, Combined; Oral Contraceptives--side effects; Parity; Physiology; Population; Population Characteristics; Population Dynamics; Prospective Studies; Research Methodology; Studies